PolyPeptide Group AG (XSWX:PPGN) Valuation Rank


XSWX:PPGN PolyPeptide Group AG XSWX:PPGN
73 GF Score
Price CHF49.40
GF Value CHF30.88
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is PolyPeptide Group AG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

PolyPeptide Group AG Valuation Rank Related Terms

XSWX:PPGN
73GF Score
PolyPeptide Group AG XSWX:PPGN
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PolyPeptide Group AG (XSWX:PPGN) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of CHF49.40 is trading 60% above its estimated GF Value™ of CHF30.88. GuruFocus considers PolyPeptide Group AG to be Significantly Overvalued.

Key valuation signals for XSWX:PPGN:

  • Valuation Rank:
  • GF Value™: CHF30.88 vs. price of CHF49.40 (60% above fair value)
  • GF Score™: 73/100 with 8 warning signs

No single metric tells the full story. See the XSWX:PPGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
73GF Score

Get the complete analysis for XSWX:PPGN

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF49.40
Price
CHF30.88
GF Value